Company issues cannabis recall due to lower THC content

A Canadian cannabis company is issuing a cannabis recall due to lower THC content. To date, HEXO has received a complaint regarding the recalled batch.

“No reports of adverse reactions related to these products have been reported to HEXO or Health Canada,” says the Health Canada advisory.

The packaging indicates the lot number “AAA-112502”. Also, it shows the total THC quantity of 12.12%, whereas the latter should be 6.36%.

Affected products of the cannabis recall

This cannabis recall involves HEXO’s HELIOS Flower dried cannabis, lot AAA-112502 sold through the Société québécoise du cannabis (SQDC).

Product Name	Product Size	Lot Number	THC Quantity
HELIOS Flower	3.5g	AAA-112502	THC total: 12.12%

Hazard identified

Furthermore, 245 units in this lot may contain a different cannabis product with a lower THC content than the labeled THC total.

Details regarding the incorrectly packaged product are below.

Product Name	Product Size	Lot Number	THC Quantity
BAYOU Flower	3.5g	AAA-112505	THC Total: 6.36%

To date, HEXO has received one complaint related to the recalled lot. On the other hand, Health Canada has not received any complaints related to the recalled lot.

To clarify, neither Health Canada nor HEXO has received any adverse reaction reports for the recalled cannabis product.

16,818 units of the recalled products were sold. The recalled product was sold from August 27th to September 6th, 2019.

Consumers must verify if their cannabis is affected

Above all, if you are in possession of the above product, please return it to the retailer you purchased it from. In addition, customers may contact the SQDC at 1-888-551-2161 for more information.

Health Canada would like to remind Canadians to report any health or safety complaints related to the use of this cannabis product by filling out the online complaint form. This also includes any other cannabis product.

The product has been identified as lot number 1204201 and bears the UPC code of 828939111631.

This is one of several recalls for cannabis since legalization in October 2018. But it is the first time an UP Cannabis Inc. product is affected. 

Previous recalls involved Redecan based in Ontario and Bonify located in Manitoba.

Cannabis recall addresses product labeling

Moreover, on November 16, 2017, Aurora Cannabis Enterprises Inc. initiated a voluntary Type II recall for one lot of Sundance Borealis blend (Sativa). Stores sell these in 5g bottles.

This was because of the packaging of the product. The THC (delta-9-tetrahydrocannabinol) content identified on the label was higher.

Also, the CBD (cannabidiol) content identified on the label was lower than the concentration present in the product.

For lot 17-118-2042, the products packaged contained a THC value of 16.2% instead of 8.17% THC. Moreover, the CBD value is 0.05% instead of 5.91% CBD.

To clarify, type II recall refers to a situation in which the use of, or exposure to a product may cause temporary adverse health consequences. Also, the probability of serious adverse health consequences is remote.

As a conclusion, to date, Health Canada has not received any adverse reaction reports for this product sold by Aurora Cannabis Enterprises Inc.

 —

(Featured image by Gisela Giardino via Wikimedia. CC BY-SA 2.0)

First published in tvanouvells.ca a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.